CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Aug. 31, 2025	May 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 223	$ 12,952
Accounts receivable	8,966	6,380
Related party receivables	9,155	9,155
Other current assets	598	598
TOTAL CURRENT ASSETS	18,942	29,085
Right-of-use asset	0	2,795
TOTAL ASSETS	18,942	31,880
CURRENT LIABILITIES
Accounts payable and accrued expenses	101,297	100,343
Deferred revenues	12,000	0
Credit cards	30,327	30,327
Accrued interest	22,095	22,095
Related-party payables	717,275	623,474
Short-term loans (net of amortization of loan fees)	111,721	111,722
SBA loans current	14,592	14,592
Derivative liabilities	0	29,322
Lease liabilities	0	4,906
Convertible note	6,363	9,182
TOTAL CURRENT LIABILITIES	1,015,670	945,963
LONG-TERM LIABILITIES
SBA loans	249,500	249,500
TOTAL LONG-TERM LIABILITIES	249,500	249,500
TOTAL LIABILITIES	1,265,170	1,195,463
STOCKHOLDERS’ DEFICIENCY
Authorized: 10,000,000 shares of preferred stock, without par value, of which 2,500,000 shares have been designated Series A Convertible Preferred Stock (2,500,000 shares outstanding at August 31, 2025, and May 31, 2025) and 2,000 shares have been designated Series B Preferred Stock (2,000 shares outstanding at August 31, 2025, and May 31, 2025)	0	0
Common Stock, without par value: 20,000,000,000 shares authorized, of which 11,626,749,347 shares were issued and outstanding at August 31, 2025, and May 31, 2025	0	0
Additional paid-in capital	4,719,318	4,719,318
Accumulated deficit	(5,965,546)	(5,882,901)
TOTAL STOCKHOLDERS’ DEFICIENCY	(1,246,228)	(1,163,583)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	$ 18,942	$ 31,880